The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Clinical Applications of Hemolytic Markers in the Differential Diagnosis and Management of Hemolytic Anemia
Open accessAbstract
Several hemolytic markers are available to guide the differential diagnosis and to monitor treatment of hemolytic conditions. They include increased reticulocytes, an indicator of marrow compensatory response, elevated lactate dehydrogenase, a marker of intravascular hemolysis, reduced haptoglobin, and unconjugated hyperbilirubinemia. The direct antiglobulin test is the cornerstone of autoimmune forms, and blood smear examination is fundamental in the diagnosis of congenital membrane defects and thrombotic microangiopathies. Marked increase of lactate dehydrogenase and hemosiderinuria are typical of intravascular hemolysis, as observed in paroxysmal nocturnal hemoglobinuria, and hyperferritinemia is associated with chronic hemolysis. Prosthetic valve replacement and stenting are also associated with intravascular and chronic hemolysis. Compensatory reticulocytosis may be inadequate/absent in case of marrow involvement, iron/vitamin deficiency, infections, or autoimmune reaction against bone marrow-precursors. Reticulocytopenia occurs in 20–40% of autoimmune hemolytic anemia cases and is a poor prognostic factor. Increased reticulocytes, lactate dehydrogenase, and bilirubin, as well as reduced haptoglobin, are observed in conditions other than hemolysis that may confound the clinical picture. Hemoglobin defines the clinical severity of hemolysis, and thrombocytopenia suggests a possible thrombotic microangiopathy or Evans’ syndrome. A comprehensive clinical and laboratory evaluation is advisable for a correct diagnostic and therapeutic workup of the different hemolytic conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of the haemoglobin scavenger receptor
Kristiansen, M., Graversen, J. H., Jacobsen, C., Sonne, O., Hoffman, H.-J., Law, S. K. A., & Moestrup, S. K. (2001) · Nature · doi:10.1038/35051594 · Cited by 1,712
Scully, M., Hunt, B. J., Benjamin, S., Liesner, R., Rose, P., Peyvandi, F., Cheung, B., Machin, S. J., & on behalf of British Committee for Standards in Haematology (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09167.x · Cited by 863
Paroxysmal nocturnal hemoglobinuria
Brodsky, R. A. (2014) · Blood · doi:10.1182/blood-2014-02-522128 · Cited by 648
Barcellini, W., Fattizzo, B., Zaninoni, A., Radice, T., Nichele, I., Di Bona, E., Lunghi, M., Tassinari, C., Alfinito, F., Ferrari, A., et al. (2014) · Blood · doi:10.1182/blood-2014-06-583021 · Cited by 382
Self-citationParoxysmal nocturnal hemoglobinuria: natural history of disease subcategories
de Latour, R. P., Mary, J. Y., Salanoubat, C., Terriou, L., Etienne, G., Mohty, M., Roth, S., de Guibert, S., Maury, S., Cahn, J. Y., et al. (2008) · Blood · doi:10.1182/blood-2008-01-133918 · Cited by 378
Haptoglobin: The Evolutionary Product of Duplication, Unequal Crossing Over, and Point Mutation
Bowman, B. H., & Kurosky, A. (1982) · Advances in Human Genetics · doi:10.1007/978-1-4615-8315-8_3 · Cited by 335
Michel, M., Chanet, V., Dechartres, A., Morin, A.-S., Piette, J.-C., Cirasino, L., Emilia, G., Zaja, F., Ruggeri, M., Andrès, E., et al. (2009) · Blood · doi:10.1182/blood-2009-04-215368 · Cited by 316
Red cell pyruvate kinase deficiency: molecular and clinical aspects
Zanella, A., Fermo, E., Bianchi, P., & Valentini, G. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05527.x · Cited by 244
Mariani, M., Barcellini, W., Vercellati, C., Marcello, A. P., Fermo, E., Pedotti, P., Boschetti, C., & Zanella, A. (2008) · Haematologica · doi:10.3324/haematol.12546 · Cited by 164
Self-citationThe Predictive Value of Serum Haptoglobin in Hemolytic Disease
Marchand, A. (1980) · JAMA · doi:10.1001/jama.1980.03300450023014 · Cited by 123
Cited by
Picard, V., Guitton, C., Thuret, I., Rose, C., Bendelac, L., Ghazal, K., Aguilar-Martinez, P., Badens, C., Barro, C., Bénéteau, C., et al. (2019) · Haematologica · doi:10.3324/haematol.2018.205328 · Cited by 128
Serum biomarkers of drug‐induced liver injury: Current status and future directions
Church, R. J., & Watkins, P. B. (2019) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12684 · Cited by 27
Sokpe, A., Mensah, M. L. K., Koffuor, G. A., Thomford, K. P., Arthur, R., Jibira, Y., Baah, M. K., Adedi, B., & Agbemenyah, H. Y. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/8833828 · Cited by 23
Metadata
- Authors
- Barcellini, W., & Fattizzo, B.
- Venue
- Disease Markers
- Publisher
- Hindawi Limited
- Published
- 2015
- Volume
- 2015
- Pages
- 1-7
- ISSN
- 0278-0240 (ISSN-L)
- 1875-8630
- OpenAlex
- W2264055547
- Cited by
- 286
- References
- 15
- FWCI
- 6.68
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical Applications of Hemolytic Markers in the Differential Diagnosis and Management of Hemolytic Anemia. https://app.cochat.ai/papers/10.1155/2015/635670
- The paper
- Barcellini, W., & Fattizzo, B. (2015). Clinical Applications of Hemolytic Markers in the Differential Diagnosis and Management of Hemolytic Anemia. Disease Markers. https://doi.org/10.1155/2015/635670
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.